Business Context and Reporting Period
This Form 8-K Current Report was filed by ShotSpotter, Inc. on April 12, 2019. The filing reports the appointment of Merline Saintil to the Company's Board of Directors as a Class I director, effective April 12, 2019. The Board size was increased to seven members, and Ms. Saintil was appointed to the Audit Committee, replacing Pascal Levensohn.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and director compensation arrangements.
Material Changes
- Board Composition: The Board of Directors increased its size by one member to seven.
- Committee Assignment: Merline Saintil was appointed to the Audit Committee.
- Compensation Grant: Ms. Saintil received an initial Restricted Stock Unit (RSU) award for 340 shares of common stock, vesting at the 2019 Annual Meeting of Stockholders.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding business operations. It details Ms. Saintil's professional background, including her role as Chief Operating Officer at Change Healthcare and prior experience at Intuit, Yahoo, and PayPal. The Company entered into a standard indemnification agreement with Ms. Saintil. Future compensation includes an Annual RSU with an aggregate fair market value of $93,750, vesting on the earlier of the 2020 annual meeting or the first anniversary of the grant date.
Investor Verification Checklist
- Verify the vesting schedule and conditions for the 340-share Initial RSU granted to Ms. Saintil.
- Confirm the date of the 2019 Annual Meeting of Stockholders to determine the exact vesting date for the Initial RSU.
- Review the Company's definitive proxy statement for the 2018 Annual Meeting to understand the full non-employee director compensation practices.
- Check for any subsequent filings regarding the valuation of the Annual RSU grant.